Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

NCT04047693 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Muscle Invasive Bladder Cancer
Urothelial Carcinoma
Neoadjuvant Chemotherapy

Interventions

DRUG: dose dense MVAC with pegylated GCSF

Sponsor

Pusan National University Yangsan Hospital